Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone pulse for lumbar disc herniation pain
IRCT20211116053077N1Phase 3Completed
- Sponsor
- Ilam University of Medical Sciences
- Start
- Feb 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of methylprednisolone sodium succinate in lumbosacral radiculopathy (2 arms), sponsored by Ilam University of Medical Sciences. Primary endpoint: low back pain. Started Feb 2022; status: completed.
02
Drugs
methylprednisolone sodium succinate
03
Conditions
lumbosacral radiculopathy
Beyond the preview
Go deeper on IRCT20211116053077N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211116053077N1.